101 related articles for article (PubMed ID: 26990536)
1. The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.
Sanz-Bueno J; Lora D; Monsálvez V; Maroñas-Jiménez L; Postigo C; Rodríguez-Peralto JL; Ortiz-Romero PL
Br J Dermatol; 2016 Oct; 175(4):794-6. PubMed ID: 26990536
[No Abstract] [Full Text] [Related]
2. Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome.
Danish HH; Liu S; Jhaveri J; Flowers CR; Lechowicz MJ; Esiashvili N; Khan MK
Leuk Lymphoma; 2016 Dec; 57(12):2813-2819. PubMed ID: 27104864
[TBL] [Abstract][Full Text] [Related]
3. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
4. Prognostic indicators for mycosis fungoides in a Greek population.
Nikolaou V; Papadavid E; Patsatsi A; Siakantaris M; Economidi A; Marinos L; Koletsa T; Georgiou E; Pappa V; Stratigos A; Antoniou C
Br J Dermatol; 2017 May; 176(5):1321-1330. PubMed ID: 27552962
[TBL] [Abstract][Full Text] [Related]
5. Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome.
Novelli S; García-Muret P; Mozos A; Sierra J; Briones J
Leuk Lymphoma; 2016 May; 57(5):1060-6. PubMed ID: 27096891
[TBL] [Abstract][Full Text] [Related]
6. Stage I mycosis fungoides: frequent association with a favourable prognosis but disease progression and disease-specific mortality may occur.
Wernham AG; Shah F; Amel-Kashipaz R; Cobbold M; Scarisbrick J
Br J Dermatol; 2015 Nov; 173(5):1295-7. PubMed ID: 26053896
[No Abstract] [Full Text] [Related]
7. Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome.
Evans KG; Troxel AB; DeNardo BJ; Introcaso CE; Rook AH; Kim EJ
J Am Acad Dermatol; 2011 Apr; 64(4):682-9. PubMed ID: 21315479
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides.
Amorim GM; Corbellini JPN; Quintella DC; Cuzzi T; Ramos-E-Silva M
An Bras Dermatol; 2018; 93(5):680-685. PubMed ID: 30156617
[TBL] [Abstract][Full Text] [Related]
9. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
10. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
13. A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides.
Mashima E; Sawada Y; Yamaguchi T; Yoshioka H; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
Clin Immunol; 2018 Aug; 193():121-122. PubMed ID: 29391198
[No Abstract] [Full Text] [Related]
14. CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact.
Jullié ML; Carlotti M; Vivot A; Beylot-Barry M; Ortonne N; Frouin E; Carlotti A; de Muret A; Balme B; Franck F; Merlio JP; Vergier B
Am J Surg Pathol; 2013 Dec; 37(12):1845-54. PubMed ID: 24145652
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte sedimentation rate as an independent prognostic factor in mycosis fungoides.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Br J Dermatol; 2012 Apr; 166(4):873-4. PubMed ID: 22059808
[TBL] [Abstract][Full Text] [Related]
16. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
[TBL] [Abstract][Full Text] [Related]
17. Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis.
Mourad A; Gniadecki R
J Invest Dermatol; 2020 Feb; 140(2):495-497.e5. PubMed ID: 31465745
[No Abstract] [Full Text] [Related]
18. Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
J Am Acad Dermatol; 2014 Sep; 71(3):529-35. PubMed ID: 24836079
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
Kim YH; Bishop K; Varghese A; Hoppe RT
Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
[TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides.
Camisa C
J Am Acad Dermatol; 1980 Mar; 2(3):242-3. PubMed ID: 7364984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
